Med

Med is a flagship medical journal from Cell Press. It publishes transformative science across the clinical and translational research continuum, from clinical trials to translational studies with demonstrable functional impact. The journal aims to bridge the bench-to-bedside gap by bringing together cutting-edge medical thinking and advances in biotechnology, pharmacology, and clinical research. We seek work that provides robust evidence to inform changes in clinical practice and health policy, improve health outcomes, and advance the exchange of knowledge across medicine.

Med also recognizes that health is shaped by factors extending beyond clinical care, including socioeconomic, geopolitical, and environmental conditions. We welcome research and perspectives that consider these broader determinants and their implications for health and medicine.

We publish original research with the potential to inform clinical practice and health policy, including randomized controlled trials; longitudinal cohort and epidemiological studies; meta-analyses of clinical observations and trials; case reports and case series of rare diseases; first-in-human pilot trials of new therapeutics; and discoveries about disease mechanisms with clear clinical relevance. We also publish cutting-edge Reviews and Perspectives on critical health issues at global and regional levels, as well as discussions that bring biomedical researchers, physicians, health scientists, and other stakeholders into conversation.

Topics of interest to Med include, but are not limited to:

• Cancer

• Cardiovascular and metabolic diseases

• Clinical practice guidelines

• Digital health

• Healthy aging

• Immunology

• Infectious diseases

• Mental health

• Neurology

• Public health and epidemiology